<DOC>
	<DOCNO>NCT01160419</DOCNO>
	<brief_summary>The rationale NEO-FLOT-trial consist intensification neoadjuvant treatment . This strategy base upon clear advantage perioperative treatment fact , former trial adjuvant treatment could give half patient ( Cunningham 2006 , Boige 2007 ) . In study neoadjuvant chemotherapy apply period 12 week interim stag 6 weeks.Due favourable efficacy toxicity data FLOT-regimen chosen neoadjuvant treatment consist oxaliplatin , docetaxel , folinic acid 5-Fluorouracil ( Al-Batran 2008 ) . Postoperative treatment accord result MAGIC trail part trail give responsibility participate centre .</brief_summary>
	<brief_title>Multicenter Study Perioperative Chemotherapy Resectable Adenocarcinoma Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>Histologically Confirmed Adenocarcinoma Gastroesophageal Junction ( AEG IIII ) Gastric Adenocarcinoma ( every T , N+ T3/T4 , Nx , M0 ) Written Informed Consent Age ≥ 18 Years Expected operability ECOG ≤ 2 Exclusion Peritoneal Metastasis Adequate Hematological , Renal , Cardiac Hepatic Function Effective Contraception Prior Chemotherapy Radiotherapy Adenocarcinoma Gastroesophageal Junction ( AEG IIII ) Gastric Adenocarcinoma Not Histologically Confirmed Primary Tumor Distant Metastasis , Local Relapse Known Hypersensitivity 5Fluorouracil , Leucovorin , Oxaliplatin Docetaxel Known DihydropyrimidinDehydrogenase ( DPD ) Deficiency Peripheral Polyneuropathy ≥ Grade II ( NCICTCAE , Version 3.0 ) Myocardial Infarction last 3 Months , Cardiac Insufficiency Grade IIIV ( NYHA ) Severe Comorbidity Acute Infections Pregnancy Breast Feeding Insufficient Contraception Participation another Clinical Trial ( Simultaneously 30 Days Prior Enrollment ) Malignancy &lt; 5 year ( except : Carcinoma In Situ Cervix Uteri Adequately Treated Basalioma Skin ) Lack Legal Capacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>